PL2890360T4 - Wyjałowiona kompozycja zawierająca co najmniej jeden kwas hialuronowy i askorbylofosforan magnezu - Google Patents

Wyjałowiona kompozycja zawierająca co najmniej jeden kwas hialuronowy i askorbylofosforan magnezu

Info

Publication number: PL2890360T4
Authority: PL; Poland
Prior art keywords: hyaluronic acid; ascorbyl phosphate; magnesium ascorbyl; sterilised composition; sterilised
Prior art date: 2012-08-29

Application number

PL13779124T

Other languages

English (en)

Other versions

PL2890360T3 (pl

Inventor

Jérémie BON BETEMPS

Estelle Piron

Original Assignee

Laboratoires Vivacy

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-08-29

Filing date

2013-08-29

Publication date

2022-04-04

2013-08-29 Application filed by Laboratoires Vivacy filed Critical Laboratoires Vivacy

2022-04-04 Publication of PL2890360T3 publication Critical patent/PL2890360T3/pl

2022-04-04 Publication of PL2890360T4 publication Critical patent/PL2890360T4/pl

Links

KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title 1
229920002674 hyaluronan Polymers 0.000 title 1
229960003160 hyaluronic acid Drugs 0.000 title 1
229940078752 magnesium ascorbyl phosphate Drugs 0.000 title 1
HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/447—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof containing sulfur
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/91—Injection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/428—Vitamins, e.g. tocopherol, riboflavin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/36—Sulfur-, selenium-, or tellurium-containing compounds
- C08K5/41—Compounds containing sulfur bound to oxygen
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/49—Phosphorus-containing compounds
- C08K5/51—Phosphorus bound to oxygen
- C08K5/52—Phosphorus bound to oxygen only
- C08K5/529—Esters containing heterocyclic rings not representing cyclic esters of phosphoric or phosphorous acids

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Birds (AREA)
Dermatology (AREA)
Transplantation (AREA)
Oral & Maxillofacial Surgery (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Polymers & Plastics (AREA)
Gerontology & Geriatric Medicine (AREA)
Dispersion Chemistry (AREA)
Biomedical Technology (AREA)
Materials Engineering (AREA)
Biochemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Cosmetics (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL13779124T 2012-08-29 2013-08-29 Wyjałowiona kompozycja zawierająca co najmniej jeden kwas hialuronowy i askorbylofosforan magnezu PL2890360T4 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US201261694527P	2012-08-29	2012-08-29
FR1258082A FR2994846B1 (fr)	2012-08-29	2012-08-29	Composition, sterilisee, comprenant au moins un acide hyaluronique et de l'ascorbyl phosphate de magnesium
EP13779124.0A EP2890360B1 (fr)	2012-08-29	2013-08-29	Composition, sterilisee, comprenant au moins un acide hyaluronique et de l'ascorbyl phosphate de magnesium
PCT/EP2013/002597 WO2014032804A1 (fr)	2012-08-29	2013-08-29	Composition, sterilisee, comprenant au moins un acide hyaluronique et de l'ascorbyl phosphate de magnesium

Publications (2)

Publication Number	Publication Date
PL2890360T3 PL2890360T3 (pl)	2022-04-04
PL2890360T4 true PL2890360T4 (pl)	2022-04-04

Family

ID=47191936

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL13779124T PL2890360T4 (pl)	2012-08-29	2013-08-29	Wyjałowiona kompozycja zawierająca co najmniej jeden kwas hialuronowy i askorbylofosforan magnezu

Country Status (17)

Country	Link
US (2)	US9402799B2 (pl)
EP (2)	EP2890360B1 (pl)
JP (1)	JP2015526489A (pl)
KR (1)	KR20150046307A (pl)
CN (2)	CN104582672B (pl)
AU (1)	AU2013307648B2 (pl)
BR (1)	BR112015004370A2 (pl)
CA (1)	CA2881750A1 (pl)
CR (1)	CR20150174A (pl)
ES (1)	ES2905049T3 (pl)
FR (1)	FR2994846B1 (pl)
IL (1)	IL237202A0 (pl)
MX (1)	MX354543B (pl)
PL (1)	PL2890360T4 (pl)
RU (1)	RU2639136C2 (pl)
SG (2)	SG11201501215YA (pl)
WO (1)	WO2014032804A1 (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2484387A1 (en)	2011-02-03	2012-08-08	Q-Med AB	Hyaluronic acid composition
KR102015676B1 (ko)	2011-06-03	2019-10-21	알러간, 인코포레이티드	항산화제를 포함하는 피부 충전제 조성물
US9393263B2 (en)	2011-06-03	2016-07-19	Allergan, Inc.	Dermal filler compositions including antioxidants
US9408797B2 (en)	2011-06-03	2016-08-09	Allergan, Inc.	Dermal filler compositions for fine line treatment
US20130096081A1 (en)	2011-06-03	2013-04-18	Allergan, Inc.	Dermal filler compositions
ES2837626T3 (es)	2013-07-10	2021-07-01	Matrix Biology Inst	Composiciones de hialuronano con alta elasticidad y usos de las mismas
US9421198B2 (en)	2013-07-30	2016-08-23	Teoxane	Composition comprising hyaluronic acid and mepivacaine
FR3015290B1 (fr) *	2013-12-23	2017-01-13	Lab Vivacy	Compositions d'acide hyaluronique compreant de la mepivacaine
EP2937074A1 (de) *	2014-04-25	2015-10-28	Petra Reinacher	Topisch anwendbare Zubereitung mit Methylsulfonylmethan zur Verbesserung der Vernarbung
US10004824B2 (en)	2015-05-11	2018-06-26	Laboratoires Vivacy	Compositions comprising at least one polyol and at least one anesthetic
FR3036035B1 (fr) *	2015-05-11	2018-10-05	Laboratoires Vivacy	Compositions comprenant au moins un polyol et au moins un anesthesique
ITUB20153110A1 (it) *	2015-08-13	2017-02-13	Alfakjn S R L	Composizione liquida iniettabile per uso nella terapia infiltrativa intra-articolare
RU2020123728A (ru) *	2015-09-24	2021-01-18	Матрикс Байолэджи Инститьют	Композиции гиалуроновой кислоты с высокоэластичными свойствами и способы их применения
WO2017101993A1 (fr) *	2015-12-16	2017-06-22	Laboratoires Vivacy	Composition d'acide hyaluronique pour injections peniennes
WO2017102001A1 (fr)	2015-12-16	2017-06-22	Vplus International Sa	Composition d'acide hyaluronique pour injections peniennes
AU2017329872A1 (en) *	2016-09-21	2019-04-11	Nestlé Skin Health Sa	Hyaluronic acid gel with a divalent zinc cation
FR3058064B1 (fr)	2016-10-28	2020-08-07	Lab Vivacy	Composition a base d'acide hyaluronique comprenant de la mepivacaine
EP3354258A1 (en) *	2017-01-31	2018-08-01	Teoxane SA	Use of a cohesive gel as a matrix material in a periodontal pocket
FR3109153B1 (fr)	2020-04-10	2022-07-15	Teoxane SA	Compositions à base d’au moins deux glycosaminoglycanes

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2958121A (en)	1955-09-20	1960-11-01	Gen Electric	Method of forming integral finned sheathed heaters
FR1352971A (fr)	1963-01-09	1964-02-21	Siemens Ag	Montage pour mesurer l'éloignement des défauts sur des lignes
JPH02215707A (ja)	1989-02-15	1990-08-28	Chisso Corp	皮膚化粧料
CA1340994C (en)	1989-09-21	2000-05-16	Rudolf Edgar Dr. Falk	Treatment of conditions and disease
CA2061703C (en)	1992-02-20	2002-07-02	Rudolf E. Falk	Formulations containing hyaluronic acid
CA2061566C (en)	1992-02-20	2002-07-09	Rudolf E. Falk	Treatment of disease employing hyaluronic acid and nsaids
CA2122551A1 (en)	1994-04-29	1995-10-30	Rudolf Edgar Falk	Clearing of atherosclerosis
CA2268476A1 (en)	1991-07-03	1998-04-30	Hyal Pharmaceutical Corporation	Use of hyaluronan in gene therapy
CA2079205C (en)	1992-09-25	1998-02-10	Rudolf Edgar Falk	Use of hyaluronic acid and forms to prevent arterial restenosis
CA2122519C (en)	1994-04-29	2001-02-20	Rudolf Edgar Dr. Falk	Cancer treatment and metastasis prevention
WO1994007505A1 (en)	1991-07-03	1994-04-14	Norpharmco Inc.	Use of hyaluronic acid and forms to prevent arterial restenosis
US5834444A (en)	1991-07-03	1998-11-10	Hyal Pharmaceutical Corporation	Hyaluronic acid and salts thereof inhibit arterial restenosis
AU3159595A (en)	1994-08-30	1996-03-22	Hyal Pharmaceutical Corporation	Hyaluronic acid and derivatives for modulation of cellular activity
FR2737971B1 (fr)	1995-08-25	1997-11-14	Lvmh Rech	Utilisation de la vitamine c ou de ses derives ou analogues pour stimuler la synthese de l'elastine cutanee
AU3368999A (en)	1998-03-31	1999-10-18	Mary Kay Inc.	Skin lightening composition containing magnesium ascorbyl phosphate and uninontan-u34tm (extract formulation of cucumber extract and lemon extract)
GB9902412D0 (en)	1999-02-03	1999-03-24	Fermentech Med Ltd	Process
US6184247B1 (en)	1999-05-21	2001-02-06	Amway Corporation	Method of increasing cell renewal rate
FR2861734B1 (fr)	2003-04-10	2006-04-14	Corneal Ind	Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
CA2519798A1 (fr)	2003-05-30	2004-12-09	Nikolai Alexeevitch Kostelev	Produit cosmetique
FR2895907B1 (fr)	2006-01-06	2012-06-01	Anteis Sa	Gel viscoelastique a usage dermatologique
US20070237816A1 (en) *	2006-04-06	2007-10-11	David Finkelstein	Acetaminophen formulation for joint pain relief
FR2909560B1 (fr) *	2006-12-06	2012-12-28	Fabre Pierre Dermo Cosmetique	Gel d'acide hyaluronique pour injection intradermique
WO2009014559A2 (en) *	2007-03-30	2009-01-29	The Board Of Regents Of The University Of Oklahoma	Heparosan-based biomaterials and coatings and methods of production and use thereof
US9011894B2 (en)	2007-06-29	2015-04-21	Carbylan Therapeutics, Inc.	Sterile hyaluronic acid polymer compositions and related methods
FR2918276B1 (fr)	2007-07-02	2010-01-22	Anteis Sa	"utilisation d'un gel de polysaccharide(s)naturel(s)pour la preparation d'une formulation injectable de traitement des degenerescences articulaires"
FR2924615B1 (fr) *	2007-12-07	2010-01-22	Vivacy Lab	Hydrogel cohesif biodegradable.
US20110171310A1 (en) *	2010-01-13	2011-07-14	Allergan Industrie, Sas	Hydrogel compositions comprising vasoconstricting and anti-hemorrhagic agents for dermatological use
US20110172180A1 (en) *	2010-01-13	2011-07-14	Allergan Industrie. Sas	Heat stable hyaluronic acid compositions for dermatological use
EP2484387A1 (en) *	2011-02-03	2012-08-08	Q-Med AB	Hyaluronic acid composition
FR2983483B1 (fr)	2011-12-02	2014-11-14	Vivacy Lab	Procede de substitution et reticulation simultanees d'un polysaccharide via ses fonctions hydroxyles

2012
- 2012-08-29 FR FR1258082A patent/FR2994846B1/fr active Active
2013
- 2013-08-29 KR KR20157007792A patent/KR20150046307A/ko not_active Withdrawn
- 2013-08-29 ES ES13779124T patent/ES2905049T3/es active Active
- 2013-08-29 SG SG11201501215YA patent/SG11201501215YA/en unknown
- 2013-08-29 BR BR112015004370A patent/BR112015004370A2/pt not_active IP Right Cessation
- 2013-08-29 JP JP2015528906A patent/JP2015526489A/ja not_active Ceased
- 2013-08-29 WO PCT/EP2013/002597 patent/WO2014032804A1/fr not_active Ceased
- 2013-08-29 CA CA2881750A patent/CA2881750A1/fr not_active Abandoned
- 2013-08-29 EP EP13779124.0A patent/EP2890360B1/fr active Active
- 2013-08-29 PL PL13779124T patent/PL2890360T4/pl unknown
- 2013-08-29 CN CN201380045060.9A patent/CN104582672B/zh active Active
- 2013-08-29 US US14/013,374 patent/US9402799B2/en active Active
- 2013-08-29 AU AU2013307648A patent/AU2013307648B2/en active Active
- 2013-08-29 CN CN201611138536.5A patent/CN106890360B/zh active Active
- 2013-08-29 EP EP20206847.4A patent/EP3797757A1/fr not_active Withdrawn
- 2013-08-29 SG SG10201705217UA patent/SG10201705217UA/en unknown
- 2013-08-29 MX MX2015002459A patent/MX354543B/es active IP Right Grant
- 2013-08-29 RU RU2015111247A patent/RU2639136C2/ru active
2015
- 2015-02-12 IL IL237202A patent/IL237202A0/en unknown
- 2015-03-27 CR CR20150174A patent/CR20150174A/es unknown
2016
- 2016-06-28 US US15/195,525 patent/US10058499B2/en active Active

Also Published As

Publication number	Publication date
FR2994846A1 (fr)	2014-03-07
SG10201705217UA (en)	2017-07-28
MX354543B (es)	2018-03-09
RU2015111247A (ru)	2016-10-27
JP2015526489A (ja)	2015-09-10
RU2639136C2 (ru)	2017-12-19
IL237202A0 (en)	2015-04-30
CN106890360B (zh)	2021-03-23
FR2994846B1 (fr)	2014-12-26
AU2013307648A1 (en)	2015-03-12
HK1208350A1 (en)	2016-03-04
CN104582672A (zh)	2015-04-29
EP3797757A1 (fr)	2021-03-31
CA2881750A1 (fr)	2014-03-06
US9402799B2 (en)	2016-08-02
PL2890360T3 (pl)	2022-04-04
SG11201501215YA (en)	2015-05-28
CN104582672B (zh)	2017-05-24
EP2890360A1 (fr)	2015-07-08
ES2905049T3 (es)	2022-04-06
BR112015004370A2 (pt)	2017-07-04
US20140088037A1 (en)	2014-03-27
US10058499B2 (en)	2018-08-28
MX2015002459A (es)	2015-06-05
AU2013307648B2 (en)	2017-09-28
KR20150046307A (ko)	2015-04-29
EP2890360B1 (fr)	2021-09-29
CR20150174A (es)	2015-08-27
CN106890360A (zh)	2017-06-27
WO2014032804A1 (fr)	2014-03-06
US20160303024A1 (en)	2016-10-20

Publication	Publication Date	Title
IL237202A0 (en)	2015-04-30	A sterilized preparation containing at least one hyaluronic acid and magnesium ascorbyl phosphate
PL2912074T3 (pl)	2019-09-30	Sterylna kompozycja do wstrzykiwania przez skórę
ZA201409229B (en)	2016-07-27	Compositions and methods for modulating utrn expression
IL252566B (en)	2020-07-30	Pharmacy preparations and methods
IL234831A0 (en)	2014-12-31	Medical preparations for combined treatment
GB201215917D0 (en)	2012-10-24	Improvements in or relating to dose indicators
ZA201501930B (en)	2016-01-27	Pharmaceutical composition
GB2501611B (en)	2015-03-04	Alpha-2-macroglobulin compositions and therapeutic uses
EP2832730A4 (en)	2015-09-09	MIRABEGRAPHIC PHARMACEUTICAL COMPOSITION
IL235211A0 (en)	2014-12-31	Injectable preparation
ZA201209705B (en)	2014-05-28	Ipmrovements in or relating to ophthalmology
SI2814473T1 (sl)	2019-03-29	Farmacevtske sestave za kombinirano terapijo
IL221087A (en)	2015-07-30	Pharmacy or nutritional composition
ZA201503171B (en)	2016-11-30	Modified hyaluronic acid derivatives and use thereof
GB201420971D0 (en)	2015-01-07	Therapeutic composition
ZA201502987B (en)	2016-11-30	Pharmaceutical composition
ZA201408065B (en)	2016-04-28	Compositions and methods for the treatment of diabetes
EP2841105A4 (en)	2016-12-21	MAGNESIUM PHOSPHATE GELS
GB201208315D0 (en)	2012-06-27	Pharmaceutical methods and compositions
GB2508793B (en)	2020-11-25	Improvements in or relating to hardware
GB201202940D0 (en)	2012-04-04	Improvements in or relating to dentures
ZA201400751B (en)	2014-12-25	Pharmaceutical composition
HUE043019T2 (hu)	2019-07-29	Gyógyszerészeti készítmények kombinációs terápia céljára